These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
435 related items for PubMed ID: 19578817
1. Proinflammatory cytokines and IL-10 in inflammatory bowel disease and colorectal cancer patients. Szkaradkiewicz A, Marciniak R, Chudzicka-Strugała I, Wasilewska A, Drews M, Majewski P, Karpiński T, Zwoździak B. Arch Immunol Ther Exp (Warsz); 2009; 57(4):291-4. PubMed ID: 19578817 [Abstract] [Full Text] [Related]
2. Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis. Niederau C, Backmerhoff F, Schumacher B, Niederau C. Hepatogastroenterology; 1997; 44(13):90-107. PubMed ID: 9058126 [Abstract] [Full Text] [Related]
3. Cytokine (TNF alpha, LT alpha and IL-10) polymorphisms in inflammatory bowel diseases and normal controls: differential effects on production and allele frequencies. Koss K, Satsangi J, Fanning GC, Welsh KI, Jewell DP. Genes Immun; 2000 Feb; 1(3):185-90. PubMed ID: 11196710 [Abstract] [Full Text] [Related]
4. Macrophages from IBD patients exhibit defective tumour necrosis factor-α secretion but otherwise normal or augmented pro-inflammatory responses to infection. Campos N, Magro F, Castro AR, Cabral J, Rodrigues P, Silva R, Appelberg R, Rodrigues S, Lopes S, Macedo G, Sarmento A. Immunobiology; 2011 Aug; 216(8):961-70. PubMed ID: 21269730 [Abstract] [Full Text] [Related]
5. Colorectal cancer complicating inflammatory bowel disease: similarities and differences between Crohn's and ulcerative colitis based on three decades of experience. Kiran RP, Khoury W, Church JM, Lavery IC, Fazio VW, Remzi FH. Ann Surg; 2010 Aug; 252(2):330-5. PubMed ID: 20622662 [Abstract] [Full Text] [Related]
10. Association of humoral markers of inflammation and dehydroepiandrosterone sulfate or cortisol serum levels in patients with chronic inflammatory bowel disease. Straub RH, Vogl D, Gross V, Lang B, Schölmerich J, Andus T. Am J Gastroenterol; 1998 Nov; 93(11):2197-202. PubMed ID: 9820396 [Abstract] [Full Text] [Related]
15. Profile of soluble cytokine receptors in Crohn's disease. Gustot T, Lemmers A, Louis E, Nicaise C, Quertinmont E, Belaiche J, Roland S, Van Gossum A, Devière J, Franchimont D. Gut; 2005 Apr; 54(4):488-95. PubMed ID: 15753533 [Abstract] [Full Text] [Related]
16. Elevated systemic levels of free interleukin-18 (IL-18) in patients with Crohn's disease. Ludwiczek O, Kaser A, Novick D, Dinarello CA, Rubinstein M, Tilg H. Eur Cytokine Netw; 2005 Apr; 16(1):27-33. PubMed ID: 15809203 [Abstract] [Full Text] [Related]
17. [Levels of cytokines in mucosal biopsies of Crohn's colitis. Physiopatological observations]. Marongiu L, Scintu F, Melis MV, Pisano M, Zorcolo L, Capra F, Casula G. Minerva Chir; 2002 Feb; 57(1):35-40. PubMed ID: 11832856 [Abstract] [Full Text] [Related]
18. Significance of inflammatory cytokines in the progression of colorectal cancer. Chung YC, Chang YF. Hepatogastroenterology; 2003 Feb; 50(54):1910-3. PubMed ID: 14696431 [Abstract] [Full Text] [Related]
19. Serum tumor necrosis factor activity in inflammatory bowel disease. Maeda M, Watanabe N, Neda H, Yamauchi N, Okamoto T, Sasaki H, Tsuji Y, Akiyama S, Tsuji N, Niitsu Y. Immunopharmacol Immunotoxicol; 1992 Feb; 14(3):451-61. PubMed ID: 1517530 [Abstract] [Full Text] [Related]
20. Colorectal cancer complicating inflammatory bowel disease: a comparative study of Crohn's disease vs ulcerative colitis in 34 patients. Ouaïssi M, Maggiori L, Alves A, Giger U, Sielezneff I, Valleur P, Sastre B, Panis Y. Colorectal Dis; 2011 Jun; 13(6):684-8. PubMed ID: 20184639 [Abstract] [Full Text] [Related] Page: [Next] [New Search]